Where in Belgium do they practice therapeutic cloning?

Therapeutic cloning is not yet applied in clinical practice (in humans), but researchers at various Flemish universities are working on fine-tuning therapeutic cloning in vitro and in animal models. For example, my research group is investigating the possibility of obtaining beta cells from human embryonic stem cells or “induced pluripotent stem cells” (iPS cells).

Beta cells are the cells absent in patients with type 1 diabetes, which normally produce and secrete insulin into the blood. People are trying to treat type 1 diabetes by transplanting beta cells, but there are not enough donors to get beta cells. Hence the interest in stem cells, which could provide an inexhaustible source for cells such as beta cells.